In the latest session, Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) closed at $13.86 down -3.21% from its previous closing price of $14.32. In other words, the price has decreased by -$0.46 from its previous closing price. On the day, 786568 shares were traded. ZNTL stock price reached its highest trading level at $14.26 during the session, while it also had its lowest trading level at $13.70.
Ratios:
For a deeper understanding of Zentalis Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.16 and its Current Ratio is at 7.16. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wedbush on November 08, 2023, Downgraded its rating to Neutral and sets its target price to $12 from $38 previously.
On November 07, 2023, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $15.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 12 ’24 when Epperly Melissa B, sold 2,573 shares for $11.44 per share. The transaction valued at 29,435 led to the insider holds 451,449 shares of the business.
Gallagher Cam sold 1,173 shares of ZNTL for $13,419 on Feb 12 ’24. The President now owns 643,277 shares after completing the transaction at $11.44 per share. On Feb 02 ’24, another insider, Gallagher Cam, who serves as the President of the company, sold 11,552 shares for $11.54 each. As a result, the insider received 133,310 and left with 644,450 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZNTL now has a Market Capitalization of 1.02B and an Enterprise Value of 577.09M.
Stock Price History:
Over the past 52 weeks, ZNTL has reached a high of $31.46, while it has fallen to a 52-week low of $9.56. The 50-Day Moving Average of the stock is 13.57, while the 200-Day Moving Average is calculated to be 19.02.
Shares Statistics:
For the past three months, ZNTL has traded an average of 875.42K shares per day and 1.15M over the past ten days. A total of 70.77M shares are outstanding, with a floating share count of 63.83M. Insiders hold about 10.05% of the company’s shares, while institutions hold 109.87% stake in the company. Shares short for ZNTL as of Feb 29, 2024 were 14.56M with a Short Ratio of 16.63, compared to 13.67M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 20.52% and a Short% of Float of 27.90%.
Earnings Estimates
There are 10 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.77 for the current quarter, with a high estimate of -$0.39 and a low estimate of -$0.96, while EPS last year was -$1.07. The consensus estimate for the next quarter is -$0.94, with high estimates of -$0.9 and low estimates of -$0.99.
Analysts are recommending an EPS of between -$3.02 and -$4.06 for the fiscal current year, implying an average EPS of -$3.66. EPS for the following year is -$3.77, with 10 analysts recommending between -$3.04 and -$4.45.
